Surgery – Means for introducing or removing material from body for... – Infrared – visible light – ultraviolet – x-ray or electrical...
Patent
1989-02-09
1992-04-28
Pellegrino, Stephen C.
Surgery
Means for introducing or removing material from body for...
Infrared, visible light, ultraviolet, x-ray or electrical...
128670, 128695, 128668, A61N 130
Patent
active
051083639
ABSTRACT:
Methods and devices for the diagnosis, evaluation and treatment of coronary artery disease (CAD) by means of a closed-loop drug delivery system that delivers an exercise simulating agent, including novel exercise simulating agents which elicit both acute and adaptive cardiovascular responses similar to those elicited by aerobic activity are provided. The acute responses to the exercise simulating agent are used to diagnose and evaluate CAD in lieu of the acute responses to aerobic exercise. Due to their adaptive responses these compounds may be used to treat CAD in lieu of the adaptive responses caused by aerobic exercise training or to treat other conditions where the adaptive responses caused by aerobic exercise are desirable.
REFERENCES:
patent: 3803230 (1974-04-01), Jack
patent: 3816516 (1974-06-01), Cox
patent: 3987200 (1976-10-01), Tuttle
patent: 4086272 (1978-04-01), Cox
patent: 4396627 (1983-08-01), Ainsworth
patent: 4562206 (1985-12-01), Tuttle
patent: 4722726 (1988-02-01), Sanderson et al.
patent: 4837305 (1989-06-01), Goodman et al.
Frucht et al., "Computer-Assisted Control of Blood Pressure by Cardiovascular Drugs: Problems in Developing a Closed-Loop Control System", Ariasth. In. 21:331-337, 1986.
Combs et al., "Evaluation of Isoproterenol as a Method of Stress Testing." Am. Hear J., 87:711-715 (1974).
Wexler et al., "Electrocardiographic Effects of Isoprenaline in Normal Subjects and Patients with Coronary Atherosclerosis." Br. Heart J., 33:759-764 (1971).
Manca et al., "Comparison of Five Different Stress Testing Methods in the ECG Diagnosis of Coronary Artery Disease: Correlation with Coronary Arteriography." Cardio., 64:325-332 (1979).
Kawashima et al., "Noninvasive Demonstration of Underlying Severe Coronary Disease in Patients with Vasospaastic Angina." Clin. Cardiol., 10:329-333 (1987).
Tuttle et al., "Dobutamine Conditions the Heat of Dogs with Surgically Narrowed Coronary Arteries." Am. J. Cardiol., 39:298-302 (1977).
Berthe et al., "Predicting the Extent and Location of Coronary Artery Disease in Acute Myocardial Infarction by Echocardiography During Dobutamine Infusion." Am. J. Cardiol., 58:1167-1172 (1979).
Mason et al., "Thallium Scintigraphy During Dobutamine Infusion." Am. Heart J., 107:481-485 (1984).
Mannering et al., "Dobutamine: An Alternate Post Infarction Stressor to Exercise Testing." JACC, 9:121A (1987).
Liang et al., "Conditioning Effects of Chronic Infusions of Dobutamine: Comparison with Exercise Training." J. Clin. Invest., 64:613-618 (1979).
Unverferth et al., "Long-Term Benefit of Dobutamine in Patients with Congestive CARDIOMYOPATHY." Am. Heart J., 100:622-630 (1980).
Leier et al., "Drug-Induced Conditioning in Congestive Heart Failure." Circulation, 65:1382-1387 (1982).
Liang et al., "Sustained Improvement of Cardiac Function in Patients with Congestive Heart Failure after Short-Term Infusion of Dobutamine." Circulation, 69:113-119 (1984).
Buttrick, "The Effects of Chronic Dobutamine Treatment of the Normotensive and Hypertensive Heart." JACC, 9:37A (1987).
Sullivan et al., "Prevention of Bederst-Induced Physical Deconditioning by Daily Dobutamine Infusions: Im;ications for Drug-Induced Physical Conditioning." J. Clin. Invest., 76:1632-1642 (1985).
Appelled et al., "Intermittent, Continuous Outpatient Dobutamine Infusion in the Management of Congestive Heart Failure." Am. J. Cardiol., 51:455-458 (1983).
Hodgson et al., "Intermittent Ambulatory Dobutamine Infusions for Patients Awaiting Cardiac Transplantation." Am. J. Cardiol., 53:375-376 (1984).
Dies, "Intermittent Dobutamine in Abulatory Patients with Chronic Cardiac Failure." Brit. J. Clin. Parc. Suppl., (oral presentation) 45:37-49.
Roffman, "Intermittent Dobutamine Hydrochloride Infusions in Outpatients with Chronic Congestive Heart Failure." Clin. Pharm, 44:194-199 (1985).
Caldwell et al., "Cardiovascular Effects of KM--13, a New, Orally Effective, Cardiotonic Sympathomimetic Amine." J. Car. Pharmacology, 9:375-384 (1987).
Sanderson et al., "Noninvasive Delivery of a Novel Inotropic Catecholamine: Iontophoretic versus Intravenous Infusions in Dogs." J. Pharm. Sci., 76:215-218 (1987).
Tuttle et al., "Dobutamine Simulates the Effects of Physical Training on Coronary and Ventricular Reserve After Myocardial Infarction." American J. of Cardiology, 19:298 (1977).
Tuttle et al., "B,-Selectivity of Dobutamine and Its Potential for Cardiovascular Therapy." Anesthesiology and Intensive Care Medicine, 118, Dobutamine, pp. 61-73 (1978).
Browne Clinton E.
Tuttle Ronald R.
Gensia Pharmaceuticals, Inc.
Pellegrino Stephen C.
Rafa Michael
LandOfFree
Diagnosis, evaluation and treatment of coronary artery disease b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis, evaluation and treatment of coronary artery disease b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis, evaluation and treatment of coronary artery disease b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1244497